Aurobindo Pharma

Market Cap (₹ Cr.)

₹91,418

52 Week High

1,584.45

Book Value

₹509

52 Week Low

834.65

PE Ratio

25.49

PB Ratio

3.06

PE for Sector

39.77

PB for Sector

4.62

ROE

10.62 %

ROCE

21.92 %

Dividend Yield

0.29 %

EPS

₹61.22

Industry

Pharmaceuticals

Sector

Pharmaceuticals - Indian - Bulk Drugs & Formln

Investment Returns

In Long Term

In Short Term

1 Year

0.00%

2 Years

0.00%

3 Years

0.00%

4 Years

0.00%

5 Years

0.00%

Growth Rate

Revenue Growth

17.55 %

Net Income Growth

64.40 %

Cash Flow Change

2.00 %

ROE

47.88 %

ROCE

46.77 %

EBITDA Margin (Avg.)

35.81 %

Financial Results

Quarterly Financials	Mar 2015	Jun 2015	Sept 2015	Dec 2015	Mar 2016	Jun 2016	Sept 2016	Dec 2016	Mar 2017	Jun 2017	Sept 2017	Dec 2017	Mar 2018	Jun 2018	Sept 2018	Dec 2018	Mar 2019	Jun 2019	Sept 2019	Dec 2019	Mar 2020	Jun 2020	Sept 2020	Dec 2020	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Revenue	2,045	2,244	2,218	2,403	2,472	2,450	2,445	2,550	2,471	2,200	3,103	2,720	2,361	2,562	3,175	3,385	3,309	3,109	3,255	3,384	3,795	3,547	4,592	3,893	4,381	2,938	2,966	2,754	3,301	1,780	2,004	2,439	2,733	2,504	2,772	3,023	3,017	2,525
Expenses	1,538	1,618	1,662	1,713	1,843	1,863	1,817	1,887	1,840	1,700	2,035	2,022	1,877	2,162	2,563	2,650	2,546	2,528	2,590	2,694	2,799	2,465	3,341	2,759	3,138	2,483	2,543	2,407	2,455	1,529	1,700	1,941	1,830	1,969	2,124	2,210	2,119	1,961
EBITDA	507	626	555	690	628	587	628	663	631	500	1,068	698	484	400	611	735	763	581	665	689	996	1,081	1,251	1,134	1,243	455	422	347	846	251	304	498	902	536	648	813	898	564
Operating Profit %	24 %	25 %	23 %	27 %	22 %	21 %	23 %	23 %	22 %	20 %	32 %	23 %	18 %	13 %	17 %	16 %	20 %	16 %	18 %	17 %	21 %	26 %	25 %	26 %	24 %	14 %	11 %	8 %	15 %	12 %	12 %	17 %	23 %	17 %	20 %	17 %	26 %	19 %
Depreciation	63	63	66	67	67	70	71	71	73	83	90	90	92	94	101	109	109	115	118	119	120	120	121	122	124	115	98	101	101	56	61	60	67	60	66	64	65	67
Interest	16	20	41	12	16	14	12	10	9	10	12	13	17	24	31	41	35	32	25	21	20	10	6	6	6	5	3	4	5	6	12	25	32	32	37	61	53	51
Profit Before Tax	428	543	449	611	545	503	545	582	549	407	966	595	375	282	479	585	618	433	522	549	856	951	1,123	1,006	1,113	335	320	242	740	189	231	413	804	444	546	687	780	446
Tax	91	135	108	147	132	112	125	141	93	99	214	150	38	55	73	110	141	82	109	119	185	245	321	268	209	143	122	89	25	77	70	123	161	116	137	137	208	120
Net Profit	337	408	341	464	413	391	419	441	455	307	753	444	308	225	381	464	460	331	398	419	718	708	797	736	873	215	198	240	802	122	165	299	645	336	416	624	579	329
EPS in ₹	11.55	13.97	5.82	8.00	7.07	6.68	7.16	7.53	7.78	5.25	12.85	7.58	5.26	3.84	6.50	7.91	7.85	5.64	6.80	7.15	12.25	12.07	13.60	12.56	14.89	3.67	3.37	4.09	13.69	2.32	2.81	5.10	11.00	5.74	7.10	10.65	9.88	5.62

Show % Change

Above figures are in Rs. Crores

Balance Sheet

Balance Sheet	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	10,226	12,566	13,023	15,794	18,141	19,564	23,189	21,601	25,059	25,154
Fixed Assets	2,190	2,568	3,212	3,393	4,150	4,418	4,472	3,586	3,688	2,419
Current Assets	6,368	7,775	6,903	8,981	10,408	11,288	12,336	9,835	9,965	7,239
Capital Work in Progress	227	742	907	1,144	789	815	735	225	239	133
Investments	20	1,183	1,682	1,968	2,339	2,527	5,010	6,584	8,105	13,393
Other Assets	7,789	8,072	7,222	9,289	10,863	11,804	12,972	11,206	13,027	9,209
Total Liabilities	4,866	5,700	4,587	5,811	6,790	6,511	7,264	4,484	7,025	5,431
Current Liabilities	3,946	5,344	4,447	5,754	6,736	6,372	6,757	4,181	6,679	5,245
Non Current Liabilities	920	356	140	57	54	139	508	303	346	186
Total Equity	5,360	6,866	8,436	9,983	11,351	13,053	15,925	17,117	18,034	19,723
Reserve & Surplus	5,330	6,807	8,378	9,924	11,292	12,994	15,866	17,059	17,975	19,664
Share Capital	29	59	59	59	59	59	59	59	59	59

Show % Change

Above figures are in Rs. Crores

Cash Flow

Cash Flow	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Cash Flow	1	310	-414	371	-171	-1	316	-335	306	-274
Investing Activities	-624	-1,390	-1,542	-991	-1,301	-948	-2,650	-1,615	-3,230	-152
Operating Activities	590	1,185	2,457	922	530	2,201	2,995	3,727	1,816	1,715
Financing Activities	35	515	-1,329	440	599	-1,255	-28	-2,448	1,719	-1,837

Show % Change

Above figures are in Rs. Crores

Share Holding

% Holding	Mar 2021	Jun 2021	Sept 2021	Dec 2021	Mar 2022	Jun 2022	Sept 2022	Dec 2022	Mar 2023	Jun 2023	Sept 2023	Dec 2023	Mar 2024	Jun 2024
Promoter	51.94 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.83 %	51.80 %
FIIs	24.37 %	23.70 %	21.71 %	21.37 %	20.83 %	20.71 %	21.40 %	22.31 %	23.02 %	24.13 %	22.45 %	20.72 %	18.02 %	16.73 %
DIIs	13.25 %	14.67 %	15.52 %	16.49 %	17.48 %	17.30 %	16.57 %	14.90 %	15.09 %	15.73 %	18.29 %	20.60 %	23.28 %	24.77 %
Government	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %	0.00 %
Public / Retail	10.45 %	9.80 %	10.93 %	10.31 %	9.86 %	10.15 %	10.20 %	10.96 %	10.05 %	8.31 %	7.42 %	6.85 %	6.87 %	6.70 %

Show % Change

Peer Comparison Compare Peers on Screener

Competitors	LTP	Market Cap (₹ Cr.)	P/E Ratio	Revenue (₹ Cr.)	YoY Revenue Growth %	Net Profit (₹ Cr.)	YoY Profit Growth %	RSI
Sun Pharmaceutical	1,853.75	4,47,463.97	42.43	49,887.17	12.06	9,648	42.62	71.70
Cipla	1,659.70	1,33,820.75	30.11	26,520.66	14.17	4,155	17.77	65.44
Zydus Life Science	1,118.55	1,12,713.30	27.04	19,831.50	13.82	3,831	30.78	42.84
Dr Reddys Laboratories	6,660.70	1,11,534.16	20.04	28,905.40	12.36	5,578	-0.90	41.66
Lupin	2,256.45	1,02,487.24	45.28	20,141.50	19.94	1,936	77.69	67.85
Mankind Pharma	2,498.80	97,436.65	49.65	10,615.63	19.57	1,942	9.89	66.36
Aurobindo Pharma	1,567.25	91,418.14	25.49	29,559.25	17.55	3,169	61.17	64.61
Alkem Laboratories	6,366.25	75,880.73	35.30	12,978.42	9.84	1,811	91.18	75.85
Glenmark Pharmaceuticals	1,753.70	49,323.67	-	12,653.09	6.58	-1,831	96.52	76.04
Biocon	378.95	45,208.59	28.97	15,621.20	35.25	1,298	478.78	60.65